CO123 An Indirect Comparison of Efgartigimod Versus Rituximab for Generalized Myasthenia Gravis
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.201
https://www.valueinhealthjournal.com/article/S1098-3015(22)02405-6/fulltext
Section Title :
Section Order :
11643
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02405-6&doi=10.1016/j.jval.2022.09.201